GlassScriptPhysician profile
Kimberly L Levinson
NPI 1104028620
$466.47
in general payments reported to CMS, 2019-2025
7 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2022: $30.93 · 2023: $45.76 · 2024: $76.34 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $258 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $258.44 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $136.80 | 2024-2025 | Lynparza, Calquence |
| Baxter Healthcare | $114.67 | 2019 | |
| Abbvie INC. | $101.10 | 2023-2025 | |
| Amag Pharmaceuticals, INC. | $34.39 | 2019 | |
| Myovant Sciences INC. | $30.93 | 2022 | |
| Merck Sharp & Dohme LLC | $28.04 | 2019-2023 | Keytruda |
| Sumitomo Pharma America, INC. | $20.54 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Levinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.